Universal Biosensors Inc logo

UBI - Universal Biosensors Inc Share Price

A$0.655 0.0  0.8%

Last Trade - 5:35am

Small Cap
Market Cap £63.5m
Enterprise Value £52.1m
Revenue £2.33m
Position in Universe 789th / 1912
Unlock UBI Revenue
Relative Strength (%)
1m -4.12%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -23.1%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
16.8 18.8 25.2 69.5 6.90 3.20 -28.2%
Balance Sheet
FINANCIAL BRIEF: : For the three months ended 31 March 2021, UniversalBiosensors, Inc. revenues increased from A$517K to A$1.5M.Net loss decreased 2% to A$1.4M. Revenues reflect Revenuefrom products increase from A$369K to A$1.2M, Revenue fromservices increase from A$148K to A$386K. Lower net lossreflects General and administrative decrease of 13% toA$1.2M (expense), Depreciation and amortization decrease of25% to A$124K (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for UBI
Graphical History


UBI Revenue Unlock UBI Revenue

Net Income

UBI Net Income Unlock UBI Revenue

Normalised EPS

UBI Normalised EPS Unlock UBI Revenue

PE Ratio Range

UBI PE Ratio Range Unlock UBI Revenue

Dividend Yield Range

UBI Dividend Yield Range Unlock UBI Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
UBI EPS Forecasts Unlock UBI Revenue
Profile Summary

Universal Biosensors, Inc. is a specialist medical diagnostics company. The Company is focused on the research, development and manufacture of in vitro diagnostic test devices for consumer and professional point-of-care use. The Company's subsidiary, Universal Biosensors Pty Ltd, conducts its research, development and manufacturing activities. The Company uses its electrochemical cell technology platform to develop point-of-care testing systems for a range of different markets. The Company is engaged in the development of its own Prothrombin Time International Normalized Ratio (PT-INR) test for use in decentralized settings, including the patient self-test market. It is engaged in demonstrating the various applications of its technology platform, including its application to diagnostic tests based on enzymatic, immunoassay and molecular diagnostic methods. It has developed a blood glucose test with LifeScan, Inc. and a coagulation PT-INR test with Siemens Healthcare Diagnostics Inc.

Last Annual December 31st, 2020
Last Interim March 31st, 2021
Incorporated September 14, 2001
Public Since December 13, 2006
No. of Shareholders: n/a
No. of Employees: 97
Sector Healthcare
Industry Healthcare Equipment & Supplies
Exchange Australian Stock Exchange - SEATS
Shares in Issue 177,621,854
Free Float (0.0%)
Eligible for
UBI Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for UBI
Upcoming Events for UBI
Friday 23rd July, 2021 Estimate
Universal Biosensors Inc Annual Shareholders Meeting
Frequently Asked Questions for Universal Biosensors Inc
What is the Universal Biosensors Inc share price?

As of 5:35am, shares in Universal Biosensors Inc are trading at A$0.655, giving the company a market capitalisation of £63.5m. This share price information is delayed by 15 minutes.

How has the Universal Biosensors Inc share price performed this year?

Shares in Universal Biosensors Inc are currently trading at A$0.655 and the price has moved by 0.233k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Universal Biosensors Inc price has moved by 0.155k% over the past year.

What are the analyst and broker recommendations for Universal Biosensors Inc?

Of the analysts with advisory recommendations for Universal Biosensors Inc, there are there are currently "buy" , "hold" and "sell" recommendations. The overall consensus recommendation for Universal Biosensors Inc is Not available. You can view the full broker recommendation list by unlocking its StockReport.

When will Universal Biosensors Inc next release its financial results?

Universal Biosensors Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2022-03-31
What is the Universal Biosensors Inc dividend yield?

Universal Biosensors Inc does not currently pay a dividend.

Does Universal Biosensors Inc pay a dividend?

Universal Biosensors Inc does not currently pay a dividend.

When does Universal Biosensors Inc next pay dividends?

Universal Biosensors Inc does not currently pay a dividend.

How do I buy Universal Biosensors Inc shares?

To buy shares in Universal Biosensors Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Universal Biosensors Inc?

Shares in Universal Biosensors Inc are currently trading at A$0.655, giving the company a market capitalisation of £63.5m.

Where are Universal Biosensors Inc shares listed? Where are Universal Biosensors Inc shares listed?

Here are the trading details for Universal Biosensors Inc:

Country of listing: Australia
Exchange: ASX
Ticker Symbol: UBI
What kind of share is Universal Biosensors Inc?

Based on an overall assessment of its quality, value and momentum, Universal Biosensors Inc is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Universal Biosensors Inc share price forecast 2021?

We were not able to load any forecast data for Universal Biosensors Inc.

How can I tell whether the Universal Biosensors Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Universal Biosensors Inc. Over the past six months, the relative strength of its shares against the market has been 67.48%. At the current price of A$0.655, shares in Universal Biosensors Inc are trading at 50.02% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Universal Biosensors Inc PE Ratio?

We were not able to find PE ratio data for Universal Biosensors Inc.

Who are the key directors of Universal Biosensors Inc?

Universal Biosensors Inc's management team is headed by:

Salesh Balak - CFO
Judith Smith - NID
David Hoey - NID
Craig Coleman - NEC
John Sharman - CEO
Who are the major shareholders of Universal Biosensors Inc?

Here are the top five shareholders of Universal Biosensors Inc based on the size of their shareholding:

Viburnum Funds Pty Ltd Private Equity
Percentage owned: 15.35% (27.2m shares)
JM Financial Group Ltd. Corporation
Percentage owned: 12.37% (22.0m shares)
Jencay Capital Pty Ltd Investment Advisor
Percentage owned: 11.71% (20.8m shares)
Richmond Hill Capital Pty. Ltd. Investment Advisor
Percentage owned: 7.07% (12.6m shares)
KFT Investments Pty. Ltd. Corporation
Percentage owned: 4.18% (7.43m shares)
Similar to UBI
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.